Daniel Ontaneda MD, PhD

Daniel Ontaneda, MD, MSc, PhD, is Associate Professor of Neurology at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University and a neurologist and neuroimmunologist at the Cleveland Clinic Neurological Institute's Mellen Center for Multiple Sclerosis. Dr. Ontaneda is the principal investigator of a multicenter study comparing highly effective versus stepwise therapeutic strategies for early relapsing-remitting multiple sclerosis (DELIVER-MS).

He is also the principal investigator of a multicenter study validating central vein imaging for the diagnosis of multiple sclerosis. He leads the observational studies group at the Mellen Center for Multiple Sclerosis. He is a member of the executive committee of the North American Imaging in Multiple Sclerosis Cooperative. Dr. Ontaneda is a member of the Multiple Sclerosis Functional Composite Task Force.

Dr. Ontaneda's studies are sponsored by the National Multiple Sclerosis Society, the National Institutes of Health, the Race to Erase Foundation, and the Patient-Centered Outcomes Research Institute. Dr. Ontaneda is a member of the editorial board of JAMA Neurology and a reviewer for Neurology, Lancet Neurology, JAMA Neurology, Annals of Neurology, and the Multiple Sclerosis Journal. Dr. Ontaneda is the author of more than 75 scientific articles in indexed journals, as well as multiple book chapters and books.

Dr. Ontaneda received his medical degree from the Pontifical Catholic University of Ecuador and a Master of Science and a PhD in clinical research from Case Western Reserve University. He completed his residency in neurology and neuroimmunology at the Cleveland Clinic Foundation and a postdoctoral fellowship at Baylor College of Medicine in Houston, Texas.